应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
FHTX Foghorn Therapeutics Inc.
盘前交易 07-11 08:12:56 EDT
5.40
-0.11
-2.00%
最高
5.50
最低
5.23
成交量
8.76万
今开
5.50
昨收
5.51
日振幅
4.90%
总市值
3.01亿
流通市值
1.40亿
总股本
5,574万
成交额
47.05万
换手率
0.34%
流通股本
2,597万
市净率
-4.88
ROE
-470.38%
每股收益
-1.34
52周最高
10.25
52周最低
2.94
市盈率
-4.03
股息
0.00
股息收益率
0.00
ROA
-23.12%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Foghorn Therapeutics Inc.2025财年第一财季实现净利润-18.83百万美元,同比增加24.74%
市场透视 · 05-22
Foghorn Therapeutics Inc.2025财年第一财季实现净利润-18.83百万美元,同比增加24.74%
Foghorn Therapeutics Inc.盘中异动 下午盘股价大跌5.31%报3.92美元
市场透视 · 05-21
Foghorn Therapeutics Inc.盘中异动 下午盘股价大跌5.31%报3.92美元
Foghorn Therapeutics Inc.盘中异动 股价大跌5.42%
市场透视 · 05-19
Foghorn Therapeutics Inc.盘中异动 股价大跌5.42%
Foghorn Therapeutics Inc.盘中异动 临近收盘股价大涨5.11%
市场透视 · 05-15
Foghorn Therapeutics Inc.盘中异动 临近收盘股价大涨5.11%
Foghorn Therapeutics Inc.盘中异动 临近午盘大幅跳水5.31%
市场透视 · 05-14
Foghorn Therapeutics Inc.盘中异动 临近午盘大幅跳水5.31%
Foghorn Therapeutics Inc.盘中异动 早盘股价大涨5.28%报4.19美元
市场透视 · 05-07
Foghorn Therapeutics Inc.盘中异动 早盘股价大涨5.28%报4.19美元
Foghorn Therapeutics Inc.盘中异动 股价大跌5.01%
市场透视 · 04-29
Foghorn Therapeutics Inc.盘中异动 股价大跌5.01%
Foghorn Therapeutics Inc.盘中异动 股价大涨8.73%报4.61美元
市场透视 · 04-23
Foghorn Therapeutics Inc.盘中异动 股价大涨8.73%报4.61美元
Foghorn Therapeutics获摩根大通证券公司首次覆盖,给予优于大市评级, 目标价9.00美元。
金融界 · 04-23
Foghorn Therapeutics获摩根大通证券公司首次覆盖,给予优于大市评级, 目标价9.00美元。
Foghorn Therapeutics Inc.盘中异动 早盘股价大跌5.28%报3.40美元
市场透视 · 04-15
Foghorn Therapeutics Inc.盘中异动 早盘股价大跌5.28%报3.40美元
Foghorn Therapeutics Inc.盘中异动 早盘股价大跌6.63%
市场透视 · 03-10
Foghorn Therapeutics Inc.盘中异动 早盘股价大跌6.63%
Foghorn Therapeutics(FHTX.US):2024年Q4财报实现营收285.6万美元,前值为576.9万美元,预期值为814万美元;每股收益为-0.23美元,前值为-0.57美元,预期值为-0.27美元。
金融界 · 03-06
Foghorn Therapeutics(FHTX.US):2024年Q4财报实现营收285.6万美元,前值为576.9万美元,预期值为814万美元;每股收益为-0.23美元,前值为-0.57美元,预期值为-0.27美元。
Foghorn Therapeutics 2024财年GAAP每股收益$(1.58)优于$(1.61)预期,销售额$2260.2万低于$3071.3万预期
财报速递 · 03-06
Foghorn Therapeutics 2024财年GAAP每股收益$(1.58)优于$(1.61)预期,销售额$2260.2万低于$3071.3万预期
Foghorn Therapeutics Inc.盘中异动 急速上涨6.29%报4.67美元
市场透视 · 03-05
Foghorn Therapeutics Inc.盘中异动 急速上涨6.29%报4.67美元
Foghorn Therapeutics Inc.盘中异动 早盘急速下挫6.19%
市场透视 · 03-03
Foghorn Therapeutics Inc.盘中异动 早盘急速下挫6.19%
Foghorn Therapeutics Inc.盘中异动 急速拉升5.18%报4.87美元
市场透视 · 02-28
Foghorn Therapeutics Inc.盘中异动 急速拉升5.18%报4.87美元
Foghorn Therapeutics Inc.盘中异动 快速下挫5.19%报4.75美元
市场透视 · 02-27
Foghorn Therapeutics Inc.盘中异动 快速下挫5.19%报4.75美元
Foghorn Therapeutics Inc.盘中异动 股价大跌5.02%
市场透视 · 02-21
Foghorn Therapeutics Inc.盘中异动 股价大跌5.02%
Foghorn Therapeutics Inc.盘中异动 早盘急速拉升5.87%
市场透视 · 02-18
Foghorn Therapeutics Inc.盘中异动 早盘急速拉升5.87%
Foghorn Therapeutics Inc.盘中异动 股价大涨5.50%报5.82美元
市场透视 · 02-13
Foghorn Therapeutics Inc.盘中异动 股价大涨5.50%报5.82美元
加载更多
公司概况
公司名称:
Foghorn Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
2020-10-23
主营业务:
Foghorn Therapeutics Inc.成立于2015年10月。该公司率先发现并开发了一类针对染色质调节系统内基因决定依赖性的药物,这是一个尚未开发的治疗机会干预。该公司专有的基因流量控制平台为其提供了一个对染色质调节系统的各个组成部分如何相互作用的综合性、机械性理解,使其能够识别、验证系统内的潜在药物靶点。
发行价格:
16.00
{"stockData":{"symbol":"FHTX","market":"US","secType":"STK","nameCN":"Foghorn Therapeutics Inc.","latestPrice":5.4,"timestamp":1752177600000,"preClose":5.51,"halted":0,"volume":87609,"delay":0,"floatShares":25974788,"shares":55741373,"eps":-1.340535,"marketStatus":"盘前交易","change":-0.11,"latestTime":"07-11 08:12:56 EDT","open":5.5,"high":5.5,"low":5.23,"amount":470454.4339143,"amplitude":0.049002,"askPrice":5.97,"askSize":100,"bidPrice":4.58,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.340535,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752240600000},"marketStatusCode":1,"adr":0,"listingDate":1603425600000,"exchange":"NASDAQ","adjPreClose":5.4,"postHourTrading":{"tag":"盘后","latestPrice":5.4,"preClose":5.4,"latestTime":"18:14 EDT","volume":316,"amount":1706.22,"timestamp":1752185653742},"volumeRatio":0.7743839586342021,"impliedVol":2.8637,"impliedVolPercentile":0.996},"requestUrl":"/m/hq/s/FHTX","defaultTab":"news","newsList":[{"id":"2537923420","title":"Foghorn Therapeutics Inc.2025财年第一财季实现净利润-18.83百万美元,同比增加24.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537923420","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537923420?lang=zh_cn&edition=full","pubTime":"2025-05-23 00:00","pubTimestamp":1747929623,"startTime":"0","endTime":"0","summary":"5月23日,Foghorn Therapeutics Inc.公布财报,公告显示公司2025财年第一财季净利润为-18.83百万美元,同比增加24.74%;其中营业收入为5.95百万美元,同比增加17.82%,每股基本收益为-0.30美元。机构评级:截至2025年5月23日,当前有6家机构对Foghorn Therapeutics Inc.目标价做出预测,其中目标均价为11.67美元,其中最低目标价为9.00美元,最高目标价为14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000050a6e913f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000050a6e913f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FHTX","LENZ"],"gpt_icon":0},{"id":"2537953382","title":"Foghorn Therapeutics Inc.盘中异动 下午盘股价大跌5.31%报3.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537953382","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537953382?lang=zh_cn&edition=full","pubTime":"2025-05-22 01:24","pubTimestamp":1747848263,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日01时24分,Foghorn Therapeutics Inc.股票出现波动,股价急速跳水5.31%。截至发稿,该股报3.92美元/股,成交量4.9895万股,换手率0.09%,振幅8.78%。Foghorn Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.10%。Foghorn Therapeutics Inc.公司简介:Foghorn Therapeutics Inc 致力于发现和开发一类新的药物,这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522012424a6e7bb33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522012424a6e7bb33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","FHTX","BK4539"],"gpt_icon":0},{"id":"2536802496","title":"Foghorn Therapeutics Inc.盘中异动 股价大跌5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536802496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536802496?lang=zh_cn&edition=full","pubTime":"2025-05-19 21:51","pubTimestamp":1747662685,"startTime":"0","endTime":"0","summary":"北京时间2025年05月19日21时51分,Foghorn Therapeutics Inc.股票出现异动,股价大幅下跌5.42%。Foghorn Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.13%。其相关个股中,Protagenic Therapeutics Inc C/Wts 26/04/2026 、Protagenic Therapeutics, Inc.、Abpro Holdings, Inc涨幅较大,Polyrizon Ltd.、Protagenic Therapeutics, Inc.、Nucana Plc较为活跃,换手率分别为7785.62%、5046.21%、2151.51%,振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Protagenic Therapeutics, Inc.、Brainstorm Cell Therapeutics Inc.,振幅分别为330.19%、64.36%、31.82%。Foghorn Therapeutics Inc.公司简介:Foghorn Therapeutics Inc 致力于发现和开发一类新的药物,这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519215126a6e4d559&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519215126a6e4d559&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","BK4539","LENZ","FHTX"],"gpt_icon":0},{"id":"2535877256","title":"Foghorn Therapeutics Inc.盘中异动 临近收盘股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535877256","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535877256?lang=zh_cn&edition=full","pubTime":"2025-05-16 03:54","pubTimestamp":1747338873,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日03时54分,Foghorn Therapeutics Inc.股票出现波动,股价急速上涨5.11%。截至发稿,该股报4.32美元/股,成交量5.7729万股,换手率0.10%,振幅6.57%。Foghorn Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为2.26%。Foghorn Therapeutics Inc.公司简介:Foghorn Therapeutics Inc 致力于发现和开发一类新的药物,这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516035433975af893&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516035433975af893&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","FHTX","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"2535907203","title":"Foghorn Therapeutics Inc.盘中异动 临近午盘大幅跳水5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535907203","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535907203?lang=zh_cn&edition=full","pubTime":"2025-05-14 23:44","pubTimestamp":1747237490,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日23时44分,Foghorn Therapeutics Inc.股票出现异动,股价大幅下跌5.31%。Foghorn Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.28%。其相关个股中,Klotho Neurosciences, Inc.、Liminatus Pharma Inc C/Wts 30/04/2030 、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大,Nucana Plc、Polyrizon Ltd.、Quoin Pharmaceuticals Ltd较为活跃,换手率分别为3879.52%、3845.53%、1551.21%,振幅较大的相关个股有Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Onconetix, Inc.,振幅分别为339.54%、201.95%、135.53%。Foghorn Therapeutics Inc.公司简介:Foghorn Therapeutics Inc 致力于发现和开发一类新的药物,这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514234450a6df265f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514234450a6df265f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FHTX","BK4139","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2533939480","title":"Foghorn Therapeutics Inc.盘中异动 早盘股价大涨5.28%报4.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533939480","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533939480?lang=zh_cn&edition=full","pubTime":"2025-05-07 21:45","pubTimestamp":1746625500,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日21时45分,Foghorn Therapeutics Inc.股票出现波动,股价快速上涨5.28%。截至发稿,该股报4.19美元/股,成交量8604股,换手率0.02%,振幅5.15%。Foghorn Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.31%。Foghorn Therapeutics Inc.公司简介:Foghorn Therapeutics Inc 致力于发现和开发一类新的药物,这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050721450094ef53f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050721450094ef53f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FHTX","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2531799196","title":"Foghorn Therapeutics Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531799196","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531799196?lang=zh_cn&edition=full","pubTime":"2025-04-30 03:54","pubTimestamp":1745956473,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日03时54分,Foghorn Therapeutics Inc.股票出现异动,股价快速下跌5.01%。Foghorn Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.55%。其相关个股中,Cyclacel Pharmaceuticals, Inc.、Biocardia, Inc.、Barinthus Biotherapeutics Plc涨幅较大,Zyversa Therapeutics, Inc.、Onconetix, Inc.、Ibio, Inc.较为活跃,换手率分别为173.31%、172.92%、149.60%,振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Ibio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028,振幅分别为134.52%、55.24%、50.68%。Foghorn Therapeutics Inc.公司简介:Foghorn Therapeutics Inc 致力于发现和开发一类新的药物,这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430035433a6cdc1fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430035433a6cdc1fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","FHTX"],"gpt_icon":0},{"id":"2529682226","title":"Foghorn Therapeutics Inc.盘中异动 股价大涨8.73%报4.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529682226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529682226?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:35","pubTimestamp":1745415344,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时35分,Foghorn Therapeutics Inc.股票出现异动,股价大幅拉升8.73%。截至发稿,该股报4.61美元/股,成交量1.0958万股,换手率0.02%,振幅5.51%。Foghorn Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.99%。Foghorn Therapeutics Inc.公司简介:Foghorn Therapeutics Inc 致力于发现和开发一类新的药物,这些药物针对染色质调节系统中基因决定的依赖性。该信息摘要如下:Foghorn Therapeutics获摩根大通证券公司首次覆盖,给予优于大市评级, 目标价9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213544a6c53e41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213544a6c53e41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FHTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2529196507","title":"Foghorn Therapeutics获摩根大通证券公司首次覆盖,给予优于大市评级, 目标价9.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529196507","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529196507?lang=zh_cn&edition=full","pubTime":"2025-04-23 19:42","pubTimestamp":1745408521,"startTime":"0","endTime":"0","summary":"Foghorn Therapeutics(FHTX.US)获摩根大通证券公司首次覆盖,给予优于大市评级, 目标价9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504231945119742103b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504231945119742103b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FHTX"],"gpt_icon":0},{"id":"2527417579","title":"Foghorn Therapeutics Inc.盘中异动 早盘股价大跌5.28%报3.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527417579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527417579?lang=zh_cn&edition=full","pubTime":"2025-04-15 21:31","pubTimestamp":1744723877,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日21时31分,Foghorn Therapeutics Inc.股票出现异动,股价急速跳水5.28%。截至发稿,该股报3.40美元/股,成交量1285股,换手率0.00%,振幅2.65%。Foghorn Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.40%。Foghorn Therapeutics Inc.公司简介:Foghorn Therapeutics Inc 致力于发现和开发一类新的药物,这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041521311894d62a71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041521311894d62a71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","FHTX","LENZ"],"gpt_icon":0},{"id":"2518126227","title":"Foghorn Therapeutics Inc.盘中异动 早盘股价大跌6.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518126227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518126227?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:36","pubTimestamp":1741613793,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时36分,Foghorn Therapeutics Inc.股票出现波动,股价大幅下挫6.63%。Foghorn Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.42%。其相关个股中,Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大,Scisparc Ltd.、Dogwood Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃,换手率分别为447.98%、67.42%、50.45%,振幅较大的相关个股有Akero Therapeutics, Inc.、Seer, Inc.、珐博进,振幅分别为100.05%、98.72%、98.49%。Foghorn Therapeutics Inc.公司简介:Foghorn Therapeutics Inc 致力于发现和开发一类新的药物,这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213633a26a26ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213633a26a26ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FHTX","LENZ"],"gpt_icon":0},{"id":"2517147501","title":"Foghorn Therapeutics(FHTX.US):2024年Q4财报实现营收285.6万美元,前值为576.9万美元,预期值为814万美元;每股收益为-0.23美元,前值为-0.57美元,预期值为-0.27美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517147501","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517147501?lang=zh_cn&edition=full","pubTime":"2025-03-07 07:03","pubTimestamp":1741302184,"startTime":"0","endTime":"0","summary":"Foghorn Therapeutics(FHTX.US):2024年Q4财报实现营收285.6万美元,前值为576.9万美元,预期值为814万美元;每股收益为-0.23美元,前值为-0.57美元,预期值为-0.27美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07070348578858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["FHTX","LENZ"],"gpt_icon":0},{"id":"1161545004","title":"Foghorn Therapeutics 2024财年GAAP每股收益$(1.58)优于$(1.61)预期,销售额$2260.2万低于$3071.3万预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1161545004","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161545004?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:18","pubTimestamp":1741295920,"startTime":"0","endTime":"0","summary":"Foghorn Therapeutics 报告季度每股亏损$,优于分析师预期的$,超出1.86%。公司报告季度销售额为$2260.2万,低于分析师预期的$3071.3万,低于预期26.41%。相比去年同期的$3415.5万,减少了33.83%。以上内容来自Benzinga Earnings专栏,原文如下:Foghorn $Therapeutics$ reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 1.86 percent. This is a 32.48 percent increase over losses of $ per share from the same period last year. The company reported quarterly sales of $22.602 million which missed the analyst consensus estimate of $30.713 million by 26.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","FHTX"],"gpt_icon":0},{"id":"2517592359","title":"Foghorn Therapeutics Inc.盘中异动 急速上涨6.29%报4.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517592359","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517592359?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:59","pubTimestamp":1741201172,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日02时59分,Foghorn Therapeutics Inc.股票出现波动,股价快速上涨6.29%。截至发稿,该股报4.67美元/股,成交量2.7506万股,换手率0.05%,振幅6.43%。Foghorn Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.70%。Foghorn Therapeutics Inc.公司简介:Foghorn Therapeutics Inc 致力于发现和开发一类新的药物,这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306025933a26111d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306025933a26111d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","FHTX"],"gpt_icon":0},{"id":"2516634467","title":"Foghorn Therapeutics Inc.盘中异动 早盘急速下挫6.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634467","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634467?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:37","pubTimestamp":1741012643,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时37分,Foghorn Therapeutics Inc.股票出现波动,股价急速下挫6.19%。Foghorn Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.08%。其相关个股中,Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大,Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃,换手率分别为48.51%、32.99%、31.59%,振幅较大的相关个股有Entero Therapeutics Inc.、Pliant Therapeutics, Inc.、Spruce Biosciences, Inc.,振幅分别为21.22%、19.85%、19.25%。Foghorn Therapeutics Inc.公司简介:Foghorn Therapeutics Inc 致力于发现和开发一类新的药物,这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032237249637add9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032237249637add9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","FHTX"],"gpt_icon":0},{"id":"2516372537","title":"Foghorn Therapeutics Inc.盘中异动 急速拉升5.18%报4.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516372537","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516372537?lang=zh_cn&edition=full","pubTime":"2025-03-01 01:09","pubTimestamp":1740762550,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日01时09分,Foghorn Therapeutics Inc.股票出现波动,股价急速拉升5.18%。截至发稿,该股报4.87美元/股,成交量2.5705万股,换手率0.05%,振幅5.62%。Foghorn Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.48%。Foghorn Therapeutics Inc.公司简介:Foghorn Therapeutics Inc 致力于发现和开发一类新的药物,这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301010911a25827fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301010911a25827fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FHTX"],"gpt_icon":0},{"id":"2514380125","title":"Foghorn Therapeutics Inc.盘中异动 快速下挫5.19%报4.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514380125","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514380125?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:53","pubTimestamp":1740675183,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时53分,Foghorn Therapeutics Inc.股票出现异动,股价快速下跌5.19%。截至发稿,该股报4.75美元/股,成交量4.439万股,换手率0.08%,振幅7.58%。Foghorn Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.39%。Foghorn Therapeutics Inc.公司简介:Foghorn Therapeutics Inc 致力于发现和开发一类新的药物,这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228005303a2569c31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228005303a2569c31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FHTX"],"gpt_icon":0},{"id":"2513291109","title":"Foghorn Therapeutics Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513291109","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513291109?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:09","pubTimestamp":1740150579,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时09分,Foghorn Therapeutics Inc.股票出现异动,股价大幅下挫5.02%。截至发稿,该股报5.11美元/股,成交量4.9109万股,换手率0.09%,振幅7.62%。Foghorn Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.14%。Foghorn Therapeutics Inc.公司简介:Foghorn Therapeutics Inc 致力于发现和开发一类新的药物,这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221230939962b8476&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221230939962b8476&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","FHTX"],"gpt_icon":0},{"id":"2512169426","title":"Foghorn Therapeutics Inc.盘中异动 早盘急速拉升5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512169426","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512169426?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:31","pubTimestamp":1739889118,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时31分,Foghorn Therapeutics Inc.股票出现波动,股价快速拉升5.87%。Foghorn Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.23%。其相关个股中,Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Aditxt, Inc.涨幅较大,Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为275.68%、90.87%、59.60%,振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Allakos Inc.、Virpax Pharmaceuticals, Inc.,振幅分别为8.57%、6.84%、6.13%。Foghorn Therapeutics Inc.公司简介:Foghorn Therapeutics Inc 致力于发现和开发一类新的药物,这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223158a24aaca8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223158a24aaca8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FHTX","LENZ"],"gpt_icon":0},{"id":"2511821576","title":"Foghorn Therapeutics Inc.盘中异动 股价大涨5.50%报5.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511821576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511821576?lang=zh_cn&edition=full","pubTime":"2025-02-14 02:26","pubTimestamp":1739471165,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日02时26分,Foghorn Therapeutics Inc.股票出现波动,股价急速上涨5.50%。截至发稿,该股报5.82美元/股,成交量6.0915万股,换手率0.11%,振幅6.27%。Foghorn Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.77%。Foghorn Therapeutics Inc.公司简介:Foghorn Therapeutics Inc 致力于发现和开发一类新的药物,这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502140226059621e9b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502140226059621e9b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FHTX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.foghorntx.com","stockEarnings":[{"period":"1week","weight":0.0526},{"period":"1month","weight":0.1663},{"period":"3month","weight":0.5652},{"period":"6month","weight":0.2558},{"period":"1year","weight":0.125},{"period":"ytd","weight":0.1441}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":0.0377},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0781},{"period":"1year","weight":0.1149},{"period":"ytd","weight":0.0678}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Foghorn Therapeutics Inc.成立于2015年10月。该公司率先发现并开发了一类针对染色质调节系统内基因决定依赖性的药物,这是一个尚未开发的治疗机会干预。该公司专有的基因流量控制平台为其提供了一个对染色质调节系统的各个组成部分如何相互作用的综合性、机械性理解,使其能够识别、验证系统内的潜在药物靶点。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.156959},{"month":2,"riseRate":0.4,"avgChangeRate":0.175406},{"month":3,"riseRate":0.4,"avgChangeRate":0.017637},{"month":4,"riseRate":0.4,"avgChangeRate":-0.077983},{"month":5,"riseRate":0.4,"avgChangeRate":0.013007},{"month":6,"riseRate":0.8,"avgChangeRate":0.067343},{"month":7,"riseRate":0.8,"avgChangeRate":0.119345},{"month":8,"riseRate":0.5,"avgChangeRate":0.029106},{"month":9,"riseRate":0.5,"avgChangeRate":-0.069683},{"month":10,"riseRate":0.25,"avgChangeRate":-0.145474},{"month":11,"riseRate":0.6,"avgChangeRate":0.053069},{"month":12,"riseRate":0.6,"avgChangeRate":0.20674}],"exchange":"NASDAQ","name":"Foghorn Therapeutics Inc.","nameEN":"Foghorn Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Foghorn Therapeutics Inc.(FHTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Foghorn Therapeutics Inc.(FHTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Foghorn Therapeutics Inc.,FHTX,Foghorn Therapeutics Inc.股票,Foghorn Therapeutics Inc.股票老虎,Foghorn Therapeutics Inc.股票老虎国际,Foghorn Therapeutics Inc.行情,Foghorn Therapeutics Inc.股票行情,Foghorn Therapeutics Inc.股价,Foghorn Therapeutics Inc.股市,Foghorn Therapeutics Inc.股票价格,Foghorn Therapeutics Inc.股票交易,Foghorn Therapeutics Inc.股票购买,Foghorn Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Foghorn Therapeutics Inc.(FHTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Foghorn Therapeutics Inc.(FHTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}